Colin Greenway

PFD Report All Responded Ref: 2023-0252
Date of Report 18 July 2023
Coroner Yvonne Blake
Coroner Area Norfolk
Response Deadline est. 12 September 2023
All 1 response received · Deadline: 12 Sep 2023
Response Status
Responses 1 of 1
56-Day Deadline 12 Sep 2023
All responses received
About PFD responses

Organisations named in PFD reports must respond within 56 days explaining what actions they are taking.

Source: Courts and Tribunals Judiciary

Coroner’s Concerns
 Junior doctors incorrect prescribing despite clear guidelines.  VTE assessments not being completed on clerking a patient just on the electronic medicines prescription which is much less detailed.  Consultants stating it is the pharmacists’ job to check for errors when there is only a 3 day service by pharmacists to do this and it is intended as a safety net procedure only.  Consultants not accepting that it is their responsibility to monitor what their junior doctors are doing when prescribing new medications for patients.  3 different consultants seeing the same patient over 3 days, no continuity of care.  Patients at higher risk of an embolus not being monitored correctly or at all after initial clerking.
Responses
The Queen Elizabeth Hospital Kings Lynn NHS Foundation Trust
25 Sep 2023
The Trust removed outdated VTE guidelines, replaced them with NICE guidance, mandated VTE-specific online training for new junior doctors, and introduced a Junior Doctor Dashboard to monitor performance. They also reinforced prescribing responsibility with senior medical staff and implemented a new Patient Safety Incident Response Plan focusing on VTE. AI summary
View full response
Dear Ms Blake

Colin Greenway – Trust’s Response to Regulation 28

We write further to the Report for the Prevention of Future Deaths made under paragraph 7, Schedule 5, of the Coroners and Justice Act 2009 and regulations 28 and 29 of the Coroners (Investigations) Regulations 2013, dated 18 July 2023.

We will respond to each of Ms Blake’s areas of concern in turn and set out the actions being taken in response, as follows:

1. Junior doctors incorrect prescribing despite clear guidelines.

We have reviewed Mr Greenway’s medical records and confirm that the junior doctor who clerked him on admission prescribed the incorrect dose of thromboprophylaxis. They noted his kidney function was impaired and prescribed a renal dose, which is lower than the standard dose on account of this medication being potentially dangerous to patients with kidney injury and/or failure. The junior doctor having left the Trust and since the hearing has been in contact to say that she prescribed the renal dose anticipating that renal function might deteriorate further. However, to be in strict compliance with the Trust’s Prevention of Venous Thromboembolism (VTE) Guidelines in place at the time Mr Greenway should have been prescribed the standard dose. Our local Guidelines relating to VTE are under review, and this is due to be taken to the next Drug and Therapeutics Committee Meeting for ratification on 31 October 2023, before being referred on to our Clinical Effectiveness Executive Group for final approval. In the meantime, these local guidelines have been removed from the Trust’s intranet and replaced with a link to the appropriate NICE guidance for VTE Adults.

We recognise the importance of standardising the prescription of thromboprophylaxis across our Integrated Care Service, particularly because junior doctors regularly complete training placements in more than one Trust across the group. We are therefore consulting with our colleagues at the other acute Trusts within the Norfolk and Waveney Integrated Care System (ICS) and also with our Integrated Care Board to see how we can better regulate this.

26 September 2023 The Queen Elizabeth Hospital King’s Lynn NHS Foundation Trust We have reiterated the importance of accurate VTE risk assessment and thromboprophylaxis prescription (medication to prevent clot formation) via Trust-wide communications. We are also reviewing our induction materials to ensure these issues are given appropriate emphasis. VTE is part of our mandatory training, and our Anticoagulation team have produced a booklet which has been distributed to our junior doctors. We are looking into making this available via a QR Code, to improve accessibility.

2. VTE assessments not being completed on clerking a patient just on the electronic medicines prescription which is much less detailed.

Currently we have VTE risk assessments within our Clerking Documents, and also on ePMA, our Electronic Prescribing and Medicines Administration which is an electronic system designed to mostly replace paper drug charts. The purpose of these risk assessments is to identify potential risk factors for patients who may be at risk of VTE, and to identify any contra-indications to thromboprophylaxis. This is required because there are patients who will be at a higher risk of VTE, and those for whom thromboprophylaxis may not be suitable, such as those with a risk of bleeding. The ePMA risk assessment must be completed in order to prescribe thromboprophylaxis on the Trust’s ePMA system.

When Mr Greenway was admitted, the VTE risk assessment was completed on ePMA, but not on the paper Clerking Document. As noted at the hearing, the risk assessment in the Trust’s paper Clerking Document is more detailed than the version on ePMA, however the eMPA version is fully compliant with NICE guidance.

In consequence, we are removing the VTE risk assessment within the Clerking Documents, so that this must be completed on ePMA only. Following feedback from our clinicians, we have made the decision to retain the guidance on VTE risk factors and contraindications within the Clerking Documents. This is because our clinicians advised that they found this very helpful as a reference, and it includes more examples than the guidance on the ePMA risk assessments and is based on the Department of Health advice. When our Clerking Documents are revised and reprinted next, they will contain a check box for the Consultant to confirm that the VTE risk assessment has been completed, and the dosage checked. In the meantime, we have commissioned stickers to add these checks to the Clerking Documents, and these have been circulated to the ward clerks to be added to the existing stock of Clerking Documents.

3. Consultants stating it is the pharmacists’ job to check for errors when there is only a 3 day service by pharmacists to do this and it is intended as a safety net procedure only.

Medicines Reconciliation should be carried out within 24 hours of admission to an acute Trust, in accordance with NICE guidance. Although this is not a service which is carried out exclusively by Pharmacists, was previously a daily service provided by the Trust’s pharmacists.

Although the focus of the Coroner’s concern related to the Consultant’s perceived lack of ownership, it is important to set out the wider context in order to clarify how this can be resolved. Against a background of local and national Pharmacy staffing shortages, the Trust had reduced its ward pharmacy service including effective medicines reconciliation on admission and clinical medicines support for the medical teams by the Trust’s pharmacists, meaning that this was not taking place at weekends during Mr Greenway’s admission. The shortage of pharmacists has been identified as an area of risk, and is included on the Trust’s Risk Register.

26 September 2023 The Queen Elizabeth Hospital King’s Lynn NHS Foundation Trust There have been a number of challenges to successful recruitment and retention within the Trust’s Pharmacy team, which is currently being mitigated by the employment of 10 agency Pharmacists, to ensure compliance with checking of inpatient prescriptions and medications to be taken with the patient on discharge. To mitigate the challenges of employment within the Trust’s local area, the Trust is looking to recruit 5 Pharmacists from inside the European Economic Area. It is hoped this recruitment, together with the provision of opportunities for career growth to the EEA Pharmacists, will encourage their settlement within the King’s Lynn area and allow for greater security for the Trust in a mutually rewarding arrangement.

In the longer-term, the Trust believes a focus on education is required to improve its ability to attract quality candidates and further improve retention. The Trust is looking to increase its available trainee undergraduate placements at the earliest opportunity, as well as offering one or more apprenticeships in the field. The Trust is to recruit a dedicated Education team within the Pharmacy group, to focus on education activities and ongoing training.

With respect to consultant responsibility for Medicines Reconciliation, we confirm that senior doctors should be taking responsibility for their patients’ medications, and for oversight of prescribing and other decisions made by junior doctors working within their team, in line with GMC Guidance and our own Trust values.

4. Consultants not accepting that it is their responsibility to monitor what their junior doctors are doing when prescribing new medications for patients.

As above, we confirm that is it the expectation of the Trust that consultants accept responsibility for the junior doctors within their team in line with GMC Guidance and Trust values. This relates to prescribing new medications for patients and also for other decisions made or advice given by the junior doctors.

With respect to the prescription of thromboprophylaxis, as above we will be updating our Clerking Documents to include a specific check box for consultants to prompt confirmation that they have checked the VTE risk assessment has been completed, and they have checked the dosage prescribed.

The Trust is working to reduce the level of locum consultant cover and foster better patient ownership with a more substantive workforce.

The concerns raised in the Regulation 28 report were disseminated to all Consultants by our Interim Medical Director as points to note for their own practice, and that of their colleagues. This case was also presented at the Acute Medicine Mortality Meeting, where it was emphasised that lack of ownership is against our Trust values and GMC Guidance, and this is within expected practice for our consultants.

5. Three different consultants seeing the same patient over three days, no continuity of care.

Although we would very much wish for every patient to be able to have the same consultant for the entirety of their admission, this is not currently within our ability to provide due to pressures within the NHS leading to staffing shortages across all levels and working time requirements. A shortage of substantive consultants affects our ability to assign consultants to the same area for an extended period of time. However, we will focus on effective handover of care between consultants and improving communication.

26 September 2023 The Queen Elizabeth Hospital King’s Lynn NHS Foundation Trust

6. Patients at higher risk of an embolus not being monitored correctly or at all after initial clerking.

We would expect that VTE risk assessments and thromboprophylaxis should be reviewed within 24 hours of admission or whenever the clinical situation changes, in accordance with the Trust’s VTE guidance as included in the Clerking Document. This review is to be recorded on ePMA.

The Coroner expressed particular concern that Mr Greenway’s fluid balance charts had not been fully completed, and that considering his known dehydration, this would have greatly assisted us in making an accurate assessment of his VTE risk. We know that completion of fluid balance charts is a nationwide issue, and there are particular difficulties with this across Norfolk and Waveney because fluid balance, observations and prescriptions run across multiple electronic and paper systems. The Trust has recently completed a joint procurement exercise in conjunction with Norfolk and Norwich University Hospitals NHS Foundation Trust and James Paget University Hospitals NHS Foundation Trust to agree a supplier for an Electronic Patient Record System which will be in place across all three Acute Trusts within the ICS. This EPR will streamline our processes with respect to patient monitoring, including Fluid Balance Charts, and is estimated to be in place by 2025. Engaging in a joint exercise across the ICS will mitigate the risk of processes differing across neighbouring Trusts, and we consider that ensuring that practices are aligned across the region will particularly help junior doctors as they rotate through placements.

In the meantime, we continue to audit compliance with patient monitoring and the completion of documentation. Fluid Balance Charts are included within Tendable© audits which are completed on a monthly basis, together with other patient documentation.

In addition, we have recently designed and implemented the Trust’s Patient Safety Incident Response Plan under the new NHS Patient Safety Incident Response Framework (PSIRF). As part of this Plan, we are required to identify three areas of focus which will receive multi-disciplinary input over the coming year to identify potential improvements which can be implemented to improve patient safety in this area. PSIRF provides a framework for Trusts to put in place a Plan tailored to patient safety issues identified within that Trust, with a view to preventing similar incidents before they occur. This is a more preventative process than the previous Serious Incident Framework, which reacted to patient safety incidents. I confirm the Trust has identified VTE as one of its areas of focus for its 2023/24 Patient Safety Incident Response Plan, and we believe this will allow us to drive improvement in this area across the Trust.

I would be happy to provide you with further information if required.
Report Sections
Investigation and Inquest
On 3 November 2022 I commenced an investigation into the death of Colin Vincent GREENWAY aged 63. The investigation concluded at the end of the inquest on 17 July 2023. The medical cause of death was: 1a) Pulmonary Thromboembolism 1b) 1c)
2) The conclusion of the inquest was: Mr Colin Greenway was a relatively fit man he was a football referee. he was overweight but active and his only medication was omeprazole. He went to Cyprus with family and 5 members of his family became unwell with gastroenteritis on 11 October. Mr Greenway came back to the U.K. on the 18 October . After a few days with no improvement he was persuaded to speak with his GP who advised rest and fluids on the 19th. On 21 October took him to a walk in centre who recommended hospital. he was taken to hospital and admitted and treated with IV fluids and antibiotics. A stool sample identified camopylobacter which required specific antibiotics. He was prescribed anticoagulant at half the usual dose despite his risk factors. his blood results improved and on 25 October he was discharged he was eating and drinking. By 28th he was feeling slightly better resting in bed. On 29 October came home to find him deceased in bed. At post-mortem he was found to have developed a pulmonary embolus (P.E.).It is not possible to say if the full dose of anticoagulation would have prevented the P.E.
Circumstances of the Death
Mr Greenway went to Cyprus with his family all became ill with a gastroenteritis. Mr Greenway returned home to the U.K. on 18 October, he remained unwell with diarrhoea and nausea. He spoke to his GP on 19 October who advised rest and fluids and went with to a walk in centre on 21 October who advised him to attend hospital. He was taken to the Queen Elizabeth Hospital in King’s Lynn and admitted. He was unwell with acute kidney injury and febrile. He was given IV fluids and antibiotics and urine and stool samples sent. The junior doctor clerking him did not use the clerking booklet when performing a VTE assessment which would have guided to prescribe 40mg of enoxaparin an anti-coagulant, instead she used the VTE assessment on the electronic prescribing system which is not as detailed as the paper clerking booklet. To prescribe anticoagulants the electronic VTE assessment has to be filled in. Despite Mr Greenway’s known risk factors of age, obesity, recent infection and loss of mobility she prescribed a “renal dose” of 20mg of enoxaparin, half the usual dose. Mr Greenway’s eGFR (measurement of renal function) was 58 and the dose of anticoagulant is only supposed to be reduced if this measurement is below 30. When spoken to after Mr Greenway’s death explanation was that did this in a excess of caution despite clear guidelines. Mr Greenway remained on this dose for his entire hospital stay. No senior clinician checked this prescription, the consultant who gave evidence assumed the pharmacists would have done a reconciliation. Mr Greenway was discharged and died several days later from a pulmonary embolism. The pharmacy service at weekends at this hospital had been suspended for some time, this consultant was even aware of this. said was too busy to check individual patients’ new prescriptions on ward rounds. The pharmacy reconciliation is meant to operate as a fail safe or safety net, it is the Consultant Doctor’s responsibility to check what their junior unsupervised doctors do at the weekend when a patient is admitted. This consultant didn’t ever speak to this junior doctor about this mis-prescribing or know what action if any had been taken about it. I was informed by a senior nurse that other such drug errors have occurred since Mr Greenway died. Documentation was poor and the TRAINED NURSES are undertaking courses to show them how to complete fluid balance charts which is something I would expect them to already know how to do. The pharmacy service at the hospital is on the Risk register because of a shortage of pharmacists. Whilst the consultants, three saw Mr Greenway, continue refuse to accept responsibility for doctors prescribing this situation continues.
Copies Sent To
, Spouse Lord Chancellor Royal Pharmaceutical Society of Great Britain Department of Health Care Quality Commission HSIB Healthwatch Norfolk
Related Inquiry Recommendations

Public inquiry recommendations addressing similar themes

Hepatologist Oversight and Fibroscan Access
Infected Blood Inquiry
GP oversight of specialist care
Specialist Hepatology Centre Access
Infected Blood Inquiry
GP oversight of specialist care
Fibroscan Every Six Months
Infected Blood Inquiry
GP oversight of specialist care
Named Hepatology Nurse Specialist
Infected Blood Inquiry
GP oversight of specialist care
Annual GP Appointment for Co-morbidities
Infected Blood Inquiry
GP oversight of specialist care
Assessment for Hepatocellular Carcinoma
Infected Blood Inquiry
GP oversight of specialist care
Transfusion Committees and Tranexamic Acid - England
Infected Blood Inquiry
High-risk medication monitoring
Tranexamic Acid - Scotland, Wales and NI
Infected Blood Inquiry
High-risk medication monitoring
Responsibility for monitoring delivery of standards and quality
Mid Staffs Inquiry
GP oversight of specialist care

Data sourced from Courts and Tribunals Judiciary under the Open Government Licence.